YBL061c|YKL079w|Cell polarity
YBR023c|YKL079w|Cell polarity
YFL005w|YKL079w|smy1delta sec4-8 is synthetic lethal
YHR023w|YKL079w|synthetic growth defect
YHR142w|YKL079w|Cell polarity
YKL079w|YAL026c|Vesicular transport
YKL079w|YBL007c|Cell polarity
YKL079w|YBL061c|Cell wall organization and biogenesis
YKL079w|YBR023c|Cell wall organization and biogenesis
YKL079w|YBR200w|Cell polarity
YKL079w|YDL225w|Cytokinesis
YKL079w|YER111c|Cell cycle control
YKL079w|YER155c|Cell polarity
YKL079w|YGR188c|Mitosis
YKL079w|YHL048w|two hybrid IST hits: 1
YKL079w|YHR142w|Cell wall organization and biogenesis
YKL079w|YNL233w|Cytokinesis
YKL079w|YNL272c|smy1delta sec2-41 is synthetic lethal
YKL079w|YNL298w|Cell polarity
YKL079w|YOR326w|overexpression of Smy1p partially suppresses myo2 defects, see; smy1delta myo2-66 is synthetic lethal; suppression; synthetic lethal
YLR330w|YKL079w|Cell polarity
YMR047c|YKL079w|two hybrid IST hits: 2
